Chronic low back pain (CLBP) affects over half a billion people worldwide. Current pharmacologic treatments offer limited efficacy and carry substantial risks, warranting the development of safe and ...
Peripheral neuropathy can be a symptom of chronic Lyme disease, causing burning, tingling, and numbness in extremities ...
Treating chronic neuropathic pain with spinal cord stimulation may help prevent excess mortality associated with chronic pain ...
Botulinum toxin injections – commonly known as Botox – provided greater short-term relief from phantom limb pain than ...
Discover what to know about cannabis and a brain aneurysm—risks, recovery, and medical cautions. When celebrity Kim ...
Levofloxacin-induced myopathy is a relatively under-recognized adverse effect. Here, we present a case of myopathy affecting the iliac and gluteal muscles caused by the administration of levofloxacin.
Carla, 84, suffered from chronic back pain while living independently. She was prescribed increasingly strong pain medications, from muscle relaxants to topical anesthetics and eventually narcotics.
Dr. Steven Fox, who started a company called Akelos that works on new ways to treat pain, is very hopeful about this new drug ...
Findings show oral Mira-55 fully normalized pain and significantly reduced inflammation, supporting IND plans and reinforcing MIRA’s position in a $70 billion non-opioid pain market. MIAMI, FLORIDA / ...
The sodium channel blockers market presents opportunities in treating conditions like arrhythmias, epilepsy, and neuropathic pain due to their action on sodium channels. Emerging drugs, like evenamide ...
Key opportunities in the spinal cord stimulators market include catering to the rising chronic pain and neuropathy cases, advancements in rechargeable devices, and regional growth prospects, ...
Nexstim Plc (NXTMH:HEX) (” Nexstim ” or ” Company ”) announces the key highlights of the Company’s business operations during Q3 2025.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈